logo
logo

Laplace Interventional Inc. Announces $7.9M Series A For Its Transcatheter Tricuspid Valve Technology

Sep 02, 2021almost 4 years ago

Round Type

series a

Minneapolis

Description

Minnesota based Laplace Interventional, a medical device company developing a transcatheter tricuspid valve technology, announced today that it has closed on its Series A financing led by a non-disclosed major strategic investor along with a significant investment from ShangBay Capital, an early stage medical device investor as well as other investors including Mayo Clinic. The $7.9M Series A financing round will fund Laplace Interventional towards achieving its preclinical milestones. The company also announced the addition of two Directors to its Board including William Dai, Founding Managing Partner at ShangBay Capital.

Company Information

Company

Laplace Interventional

Location

Minneapolis, Minnesota, United States

About

Laplace Interventional is developing a prosthetic valve that shall be delivered through a minimally invasive procedure not requiring an open-heart surgery and thereby reducing future complications in patients.

FundzWatch™ Score

77
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood